Pharmacology and clinical efficacy of dalfampridine for treating multiple sclerosis
Author:
Publisher
Informa Healthcare
Subject
Pharmacology,Toxicology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/17425255.2015.993315
Reference35 articles.
1. Dalfampridine Extended Release
2. Enhancing Neural Transmission in Multiple Sclerosis (4-Aminopyridine Therapy)
3. Treatment of walking impairment in multiple sclerosis with dalfampridine
4. 4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review
5. Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS)
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Gold/4-aminopyridine mucoadhesive chitosan nanocomposites as promising nasal drug delivery system for neuroprotection – An ex vivo investigation;Emergent Materials;2024-06-25
2. Assessment of motor function in patients with multiple sclerosis treated with Fampridine using motor-evoked potentials;Balneo and PRM Research Journal;2023-12-20
3. Altered Expression of Ion Channels in White Matter Lesions of Progressive Multiple Sclerosis: What Do We Know About Their Function?;Frontiers in Cellular Neuroscience;2021-06-25
4. HPLC method development for fampridine using Analytical Quality by Design approach;Acta Pharmaceutica;2020-05-13
5. Study on Dalfampridine in the treatment of Multiple Sclerosis Mobility Disability: A meta-analysis;PLOS ONE;2019-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3